Whiteley Bactol Clear Antibacterial Hand Rub
01 March, 2021Whitely has added Bactol Clear — an antibacterial hand rub that kills bacteria without water — to its hand hygiene range.
Camfil Opakfil ES energy-saving filters
01 March, 2021Camfil Opakfil ES filters remove airborne contaminants such as smoke, bacteria, fumes, fungi and virus-bearing droplet nuclei.
Rubbermaid HYGEN Microfibre System
01 March, 2021The hygiene system is designed to completely remove microbes from surfaces and reduce the spread of infection by cleaning facilities efficiently and effectively.
Reynard Premier Detergent and Disinfectant Wipes
01 March, 2021Reynard's Premier Detergent and Disinfectant Wipes are designed to clean and disinfect hard surfaces and equipment simply and effectively while saving time and money.
Australia's COVID-19 vaccine rollout commences
23 February, 2021Australia's vaccine program kicked off at the start of this week, with the country's most vulnerable community members first off the block to receive the Pfizer–BioNTech vaccine.
DiDi supports vaccine rollout via free trips for frontline workers
19 February, 2021Rideshare service DiDi has launched a new service — DiDi Vaccinate — which will provide free trips to frontline workers to assist in the rollout of the COVID-19 vaccine in Australia.
Partnership delivers smart, reusable PPE solutions
15 February, 2021RFiD Discovery and Welspring have partnered to offer high-quality, reusable and trackable protective garments for frontline healthcare workers.
Long-lasting infection-control solution now available in Australia
12 February, 2021SurfaceWise2, a hospital-grade disinfectant that makes surfaces hostile to germs for up to three months, has been launched in Australia by Allied BioServices.
Russian Sputnik vaccine demonstrates 91.6% efficacy
08 February, 2021Preliminary results from the Russian COVID-19 phase 3 vaccine trial suggest that the two-dose vaccine regimen is 91.6% efficacious against symptomatic COVID-19.
Aus biotech company supplies at-home COVID-19 tests to US
05 February, 2021 by Lauren DavisQueensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.
Novavax vaccine demonstrates 89.3% efficacy
03 February, 2021Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.
Monash innovation reduces risk of COVID in healthcare workers
29 January, 2021A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.
TGA approves Pfizer/BioNTech vaccine
25 January, 2021The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.
GPs to take lead role in COVID-19 vaccine rollout
14 January, 2021The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.
